We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+74.55%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$611M
AUM Growth
+$189M
(+45%)
Cap. Flow
+$13.6M
Cap. Flow
% of AUM
2.23%
Top 10 Holdings %
Top 10 Hldgs %
10.32%
Holding
440
New
177
Increased
32
Reduced
81
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CALY
Callaway Golf Company
CALY
|
+$6.91M |
| 2 |
Gentex
GNTX
|
+$6.43M |
| 3 |
Artisan Partners
APAM
|
+$5.25M |
| 4 |
Shutterstock
SSTK
|
+$5.01M |
| 5 |
Vericel Corp
VCEL
|
+$3.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardiff Oncology
CRDF
|
+$5.05M |
| 2 |
Workhorse Group
WKHS
|
+$4.62M |
| 3 |
CryoPort
CYRX
|
+$4.55M |
| 4 |
SiTime
SITM
|
+$3.83M |
| 5 |
Seres Therapeutics
MCRB
|
+$3.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26% |
| 2 | Technology | 24.89% |
| 3 | Consumer Discretionary | 15.91% |
| 4 | Industrials | 14.11% |
| 5 | Financials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
CorMedix
CRMD
$584M
| $892K | 0.15% |
+120,002
| New | +$816K |
|
277
Protagonist Therapeutics
PTGX
$9.44B
| $888K | 0.15% |
44,067
-30,279
| -41% | -$652K |
|
278
Red Robin
RRGB
$152M
| $869K | 0.14% |
+45,190
| New | +$758K |
|
|
STKL
279
DELISTED
SunOpta
STKL
| $864K | 0.14% |
+74,017
| New | +$652K |
|
|
RUTH
280
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $850K | 0.14% |
47,947
-129,591
| -73% | -$1.82M |
|
281
Innovative Solutions & Support
ISSC
$361M
| $821K | 0.13% |
125,956
-3,947
| -3% | -$26.2K |
|
|
282
Cardiff Oncology
CRDF
$77.2M
| $819K | 0.13% |
45,517
-287,383
| -86% | -$5.05M |
|
|
LL
283
DELISTED
LL Flooring Holdings, Inc.
LL
| $814K | 0.13% |
26,485
-7,104
| -21% | -$198K |
|
|
AGNT
284
AGNT Inc
AGNT
$734M
| $810K | 0.13% |
25,666
-133,998
| -84% | -$3.7M |
|
|
ALPN
285
DELISTED
Alpine Immune Sciences Inc
ALPN
| $797K | 0.13% |
+63,261
| New | +$621K |
|
|
GATO
286
DELISTED
Gatos Silver, Inc.
GATO
| $788K | 0.13% |
+60,493
| New | +$463K |
|
287
Tidewater
TDW
$4.12B
| $776K | 0.13% |
+89,788
| New | +$713K |
|
|
CTIC
288
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $773K | 0.13% |
+240,108
| New | +$799K |
|
289
Johnson Outdoors
JOUT
$505M
| $747K | 0.12% |
+6,635
| New | +$603K |
|
|
KBNT
290
DELISTED
Kubient, Inc. Common Stock
KBNT
| $682K | 0.11% |
+122,168
| New | +$505K |
|
|
ACCS
291
ACCESS Newswire
ACCS
$26.2M
| $607K | 0.1% |
34,681
-18,990
| -35% | -$393K |
|
|
NOTV
292
DELISTED
Inotiv
NOTV
| $270K | 0.04% |
+21,958
| New | +$143K |
|
293
Acacia Research
ACTG
$470M
| – | – |
-183,248
| Closed | -$636K |
|
294
AudioEye
AEYE
$75M
| – | – |
-128,553
| Closed | -$1.88M |
|
|
AKRO
295
DELISTED
Akero Therapeutics
AKRO
| – | – |
-63,928
| Closed | -$1.97M |
|
296
Alto Ingredients
ALTO
$340M
| – | – |
-183,105
| Closed | -$1.34M |
|
|
GOLD
297
Gold.com Inc
GOLD
$1.26B
| – | – |
-58,720
| Closed | -$990K |
|
298
Arlo Technologies
ARLO
$1.65B
| – | – |
-228,505
| Closed | -$1.2M |
|
299
Atomera
ATOM
$214M
| – | – |
-84,112
| Closed | -$879K |
|
|
AZEK
300
DELISTED
The AZEK Co
AZEK
| – | – |
-33,673
| Closed | -$1.17M |
|
Similar funds
RWM
MCM
HP
OMG
WFAL
WCM
TSS
F1I
EAM Investors's Q4 2020 Portfolio in Review
As of Q4 2020, EAM Investors held 440 positions worth $611M, up 45% from $422M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
EAM Investors's Q4 2020 filing shows 177 new, 32 increased, 81 reduced and 148 closed positions. Its largest new stake was Callaway Golf Company: 338,637 shares worth $8.13M. The largest sale was Cardiff Oncology, an estimated $5.05M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
- EAM Investors's largest Q4 2020 buy was Callaway Golf Company: 338,637 shares worth $8.13M.
- EAM Investors added most to Artisan Partners in Q4 2020, an estimated $5.25M increase.
- EAM Investors's biggest Q4 2020 reduction was Cardiff Oncology, cutting an estimated $5.05M.
- EAM Investors fully exited Workhorse Group in Q4 2020, selling an estimated $4.62M.
- EAM Investors's ten largest holdings make up 10% of its $611M portfolio in Q4 2020.
- EAM Investors opened 177 new positions and closed 148 in Q4 2020.
- EAM Investors's portfolio value rose 45% quarter-over-quarter to $611M.
Based on EAM Investors's 13F filing for Q4 2020, filed 11 Feb 2021.